Skip To The Main Content

Explore the latest articles in the Astrodyne TDI blog:

Categories:s
Posted Under Success Stories

The LVAD is a perfect example of how Astrodyne, using a target application space approach, can help customers solve their power and EMC challenges.

Astrodyne is a global leader in the design and manufacture of power supply and EMC filter solutions. A large customer of Astrodyne is among the most prominent manufacturers of portable Left Ventricle Assist Devices (LVAD) in the world. The company received FDA approval for one platform in late 2012 and is currently developing and clinically testing its next-generation designs, which utilize new pump and control technology. In addition to the FDA approval in the United States, approval is pending from various other countries.

lvad

LVADs are mechanical circulatory devices that partially or completely replace the functions of a failing heart. Originally LVADs were intended for short-term use, typically for patients recovering from heart attacks or heart surgery, or to sustain the functions of the heart while the patient awaits a transplant, a process referred to as Bridge to Transplant. Recently regulatory bodies have begun allowing continued use of LVADs, and some devices have already logged many years with patients; this is referred to as Destination Therapy.

LVADs have existed since the 1980s, but only in the past 10 years have they been portable, giving patients the ability to receive a transplant, leave the hospital, and return to a relatively normal life. In this application space worldwide, there are about 15 companies, two of which have received full FDA approval, while the others are working through clinical trials in anticipation of receiving approval in the future.

The LVAD is a perfect example of how Astrodyne, using a target application space approach, can help customers solve their power and EMC challenges. Astrodyne has identified the needs of the Circulatory Market and is offering OEMs its experience and product. The system desires in this market are for increased patient convenience.

Astrodyne currently supplies four different Jerome Brand models of a few variations. The most notable models and examples of meeting the market need are CF, low leakage, AC-DC, and DC-DC power supplies. CF leakage occurs due to the direct connection to the patient’s body, creating a potentially harmful electrical current that must be protected against. The Jerome brand has a broad range of low CF leakage, 40–135W, input Class I & II models that fit well into these applications.

Learn more about Astrodyne and its products and capabilities, along with how the company is helping customers in a variety of industries, at www.astrodynetdi.com.